Skip to main content

Table 3 Validation results of the dementia progression rate at year 2

From: Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease

% Dementia Control (%) Intervention
Results from the LipiDiDiet trial 37 41
Results from the model (real characteristics in control and intervention groups) 41 40
Results from the model (both groups with the same baseline characteristics) 41 36
  1. CDR-SB Clinical Dementia Rating Sum of Boxes
  2. Patients with amnestic mild cognitive impairment did not have the same CDR-SB baseline characteristics in the LipiDiDiet trial. In order to overcome this limitation, we adapted intervention group characteristics to the real ones